Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
Public ClinicalTrials.gov record NCT07526545. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
UPRISE (Urine Prostate Screening Integrated With MRI for Prostate Cancer Early Detection)
Study identification
- NCT ID
- NCT07526545
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Other
- Enrollment
- 800 participants
Conditions and interventions
Conditions
Interventions
- Biopsy Procedure Procedure
- Diagnostic Procedure Device
- Electronic Health Record Review Other
- Magnetic Resonance Imaging Procedure
Procedure · Device · Other
Eligibility (public fields only)
- Age range
- 50 Years to 75 Years
- Sex
- Male
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2026
- Primary completion
- Oct 31, 2029
- Completion
- Oct 31, 2029
- Last update posted
- Apr 12, 2026
2026 – 2029
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor | Michigan | 48109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07526545, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 12, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07526545 live on ClinicalTrials.gov.